CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 15  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0669
LYS 10.0098
GLU 20.0050
LEU 30.0028
ARG 40.0067
CYS 50.0103
GLN 60.0100
CYS 70.0111
ILE 80.0172
LYS 90.0669
THR 100.0167
TYR 110.0054
SER 120.0154
LYS 130.0270
PRO 140.0098
PHE 150.0089
HIS 160.0127
PRO 170.0087
LYS 180.0141
PHE 190.0058
ILE 200.0037
LYS 210.0099
GLU 220.0084
LEU 230.0041
ARG 240.0059
VAL 250.0032
ILE 260.0049
GLU 270.0095
SER 280.0079
GLY 290.0112
PRO 300.0232
HIS 310.0092
CYS 320.0072
ALA 330.0057
ASN 340.0060
THR 350.0044
GLU 360.0039
ILE 370.0026
ILE 380.0060
VAL 390.0050
LYS 400.0086
LEU 410.0041
SER 420.0051
ASP 430.0069
GLY 440.0154
ARG 450.0202
GLU 460.0150
LEU 470.0143
CYS 480.0026
LEU 490.0032
ASP 500.0023
PRO 510.0034
LYS 520.0123
GLU 530.0095
ASN 540.0094
TRP 550.0062
VAL 560.0026
GLN 570.0077
ARG 580.0099
VAL 590.0058
VAL 600.0050
GLU 610.0172
LYS 620.0131
PHE 630.0026
LEU 640.0132
LYS 650.0250
ARG 660.0169
ALA 670.0311
GLU 680.0534
ASN 690.0452

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.